The president's state visit comes amid tensions with carmaker Toyota over potential auto tariffs. Trump has repeatedly threatened Japanese and European carmakers with tariffs.Traderead more
Microsoft shares have gained 133% since November 2015, outperforming a tech "basket of unicorns" over that stretch.Technologyread more
Buybacks have gotten a bad rap from both Republicans and Democrats. But stocks would be trading at a massive discount without them.Marketsread more
The IRS is about to release a new draft of Form W-4, which will more closely reflect the changes stemming from the Tax Cuts and Jobs Act. For workers, that means they'll need...Personal Financeread more
The Mega Millions jackpot has spilled over $400 million. It would be the ninth largest winning since the game began in 2002.Personal Financeread more
When commercial real estate investor Manny Khoshbin spent $2.2 million on the fastest production car in the world, he had no idea it would very quickly also become the...Autosread more
Trump was speaking at a meeting of Japanese business leaders in Tokyo during his state visit to Japan on Saturday.Marketsread more
The biggest U.S. gasoline price surge in years is running out of steam just in time for the start of the summer driving season.Energyread more
The federal minimum wage has remained $7.25 per hour since 2009. But several states, and even some companies, have since taken matters into their own hands to pay employees a...Workread more
Stocks rose on Friday, but notched weekly losses as investors worried the U.S.-China trade war is hurting economic growth.US Marketsread more
During the past few decades, the number of companies producing vaccines has dwindled to just a handful. There are other players in the space, but today, the four big drug companies that now dominate the market are Merck, Pfizer, Sanofi Pasteur and GlaxoSmithKline.
Selling a vaccine like Shingrix for the shingles or Gardasil 9 for HPV is where a company can make big profits. Gardasil 9 reached over $3 billion in sales in 2018 and with the patent not expiring until 2028 in the U.S., it could reach billions more, according to analysts.
Watch this video to find out what the future holds for vaccines makers Merck, Pfizer, Sanofi Pasteur and GlaxoSmithKline.